Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +2.19% inched 0.04% higher to $92.82 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.54% falling 0.72% to 3,873.33 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.11% falling 0.45% to 30,822.42. This was the stock's second consecutive day of gains. DaVita Inc. closed $31.99 below its 52-week high ($124.81), which the company achieved on April 20th.
The stock outperformed some of its competitors Friday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +1.69% fell 0.71% to $16.67, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH +1.38% fell 0.06% to $223.99, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS +1.50% fell 0.01% to $98.98. Trading volume (1.7 M) eclipsed its 50-day average volume of 742,042.